Dambkowski Carl

CIK 00019834762 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001983476

Recent Transactions

50 trades

Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-03-04$22.86/sh+4,125→ 215,273 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2026-03-04−4,125→ 131,290 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-03-04$73.26/sh−200→ 209,773 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-03-04$71.98/sh−2,075→ 209,973 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-03-04$70.33/sh−3,225→ 212,048 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-02-04$64.88/sh−2,481→ 214,167 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2026-02-04−4,125→ 135,415 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-02-04$22.86/sh+4,125→ 216,648 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-02-04$68.94/sh−200→ 211,148 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-02-04$67.88/sh−100→ 211,348 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-02-04$66.85/sh−1,299→ 211,448 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-02-04$65.83/sh−1,420→ 212,747 total
Other
Oruka Therapeutics, Inc.$ORKA
Common Stock
2026-01-23+116,483→ 116,483 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-01-07$22.86/sh+14,025→ 231,223 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-01-07$77.90/sh−14,820→ 213,449 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-01-07$77.13/sh−2,954→ 228,269 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2026-01-07−14,025→ 139,540 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-01-07$80.06/sh−100→ 212,523 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-01-07$79.04/sh−826→ 212,623 total
Award
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2026-01-02+83,690→ 83,690 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-12-04$75.00/sh−10,900→ 271,108 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-11-05$55.58/sh−5,607→ 282,686 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-11-05$53.62/sh−2,300→ 290,493 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-11-05$22.86/sh+8,060→ 292,793 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2025-11-05−8,060→ 153,565 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-11-05$56.51/sh−678→ 282,008 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-11-05$54.83/sh−2,200→ 288,293 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-10-01$39.80/sh−5,110→ 284,733 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2025-10-01−2,385→ 161,625 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-10-01$22.86/sh+2,385→ 289,843 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-09-03$37.82/sh−2,535→ 233,738 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-09-03$38.55/sh−190→ 233,548 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-08-06$37.78/sh−2,725→ 236,273 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-07-02$46.26/sh−746→ 238,998 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-07-02$44.77/sh−6,409→ 242,679 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-07-02$22.86/sh+7,365→ 249,088 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2025-07-02−7,365→ 164,010 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-07-02$45.49/sh−2,935→ 239,744 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-06-04$36.96/sh−2,725→ 241,723 total
Award
Oruka Therapeutics, Inc.$ORKA
Stock Option (right to buy)
2025-06-02+17,500→ 17,500 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-05-07$35.75/sh−2,725→ 244,448 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-04-02$37.59/sh−889→ 247,173 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-04-02$35.56/sh−2,471→ 248,562 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-04-02$37.03/sh−500→ 248,062 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-03-05$30.48/sh−1,590→ 251,033 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2025-02-05−795→ 171,375 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-02-05$22.86/sh+795→ 256,143 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-02-05$40.69/sh−3,520→ 252,623 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-01-02$47.92/sh−100→ 255,348 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-01-02$47.21/sh−2,486→ 255,448 total

Companies

Recent Filings

Address

C/O APOGEE THERAPEUTICS, INC. 221 CRESCENT ST., BLDG. 17, STE. 102B

WALTHAM, MA, 02453

View on SEC.gov